These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 36412119)

  • 21. Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model.
    Villaça CBP; de Paula CC; de Oliveira CC; Vilas-Boas EA; Dos Santos-Silva JC; de Oliveira SF; Abdulkader F; Ferreira SM; Ortis F
    Exp Physiol; 2021 Jul; 106(7):1482-1497. PubMed ID: 33913203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in β cell replacement and regeneration strategies for treating diabetes.
    Benthuysen JR; Carrano AC; Sander M
    J Clin Invest; 2016 Oct; 126(10):3651-3660. PubMed ID: 27694741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Debates in Pancreatic Beta Cell Biology: Proliferation Versus Progenitor Differentiation and Transdifferentiation in Restoring β Cell Mass.
    Spears E; Serafimidis I; Powers AC; Gavalas A
    Front Endocrinol (Lausanne); 2021; 12():722250. PubMed ID: 34421829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances and potential applications of human pluripotent stem cell-derived pancreatic β cells.
    Zhou Z; Ma X; Zhu S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):708-715. PubMed ID: 32445468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of stem cells for pancreatic regeneration in diabetes mellitus.
    Bouwens L; Houbracken I; Mfopou JK
    Nat Rev Endocrinol; 2013 Oct; 9(10):598-606. PubMed ID: 23877422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
    Agrawal A; Narayan G; Gogoi R; Thummer RP
    Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering-inspired approaches to study β-cell function and diabetes.
    Lewis PL; Wells JM
    Stem Cells; 2021 May; 39(5):522-535. PubMed ID: 33497522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.
    Zhu Y; Liu Q; Zhou Z; Ikeda Y
    Stem Cell Res Ther; 2017 Nov; 8(1):240. PubMed ID: 29096722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.
    Cui D; Feng X; Lei S; Zhang H; Hu W; Yang S; Yu X; Su Z
    Chin Med J (Engl); 2024 Apr; 137(7):791-805. PubMed ID: 38479993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Veiled Potential of Secretagogin in Diabetes: Correlation or Coincidence?
    Sharma AK; Khandelwal R; Sharma Y
    Trends Endocrinol Metab; 2019 Apr; 30(4):234-243. PubMed ID: 30772140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-cell neogenesis: A rising star to rescue diabetes mellitus.
    Niu F; Liu W; Ren Y; Tian Y; Shi W; Li M; Li Y; Xiong Y; Qian L
    J Adv Res; 2024 Aug; 62():71-89. PubMed ID: 37839502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of GPR119 Stimulates Human β-Cell Replication and Neogenesis in Humanized Mice with Functional Human Islets.
    Ansarullah ; Free C; Christopherson J; Chen Q; Gao J; Liu C; Naji A; Rabinovitch A; Guo Z
    J Diabetes Res; 2016; 2016():1620821. PubMed ID: 27413754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in organoid culture for insulin production and diabetes therapy: methods and challenges.
    Dayem AA; Lee SB; Kim K; Lim KM; Jeon TI; Cho SG
    BMB Rep; 2019 May; 52(5):295-303. PubMed ID: 30940326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus: an opportunity for therapy with stem cells?
    Sordi V; Bertuzzi F; Piemonti L
    Regen Med; 2008 May; 3(3):377-97. PubMed ID: 18462060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers.
    Chera S; Baronnier D; Ghila L; Cigliola V; Jensen JN; Gu G; Furuyama K; Thorel F; Gribble FM; Reimann F; Herrera PL
    Nature; 2014 Oct; 514(7523):503-7. PubMed ID: 25141178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis.
    Lam CJ; Jacobson DR; Rankin MM; Cox AR; Kushner JA
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2647-2659. PubMed ID: 28323930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies.
    Thakur G; Lee HJ; Jeon RH; Lee SL; Rho GJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regenerating β cells of the pancreas - potential developments in diabetes treatment.
    Dong S; Wu H
    Expert Opin Biol Ther; 2018 Feb; 18(2):175-185. PubMed ID: 29130349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The triumvirate of beta-cell regeneration: solutions and bottlenecks to curing diabetes.
    Singh SP; Ninov N
    Int J Dev Biol; 2018; 62(6-7-8):453-464. PubMed ID: 29938757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.